Status:
UNKNOWN
Remediation for Mild Cognitive Deficits After Cancer
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Cognitive Remediation
Breast Cancer
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Cancer survival rates have improved significantly over the past decades and patients now experience a number of side effects including cancer-related cognitive impairment (CRCI): problems with memory,...
Eligibility Criteria
Inclusion
- Treated in the past for breast cancer with chemotherapy, surgery, and / or radiotherapy,
- Admitted as a day patient at the Henry Gabrielle Hospital or the Pontchaillou CHU Hospital during the study,
- Given free, informed consent in writing after being informed orally and in writing of the how the study will proceed.
Exclusion
- Presence of another active cancer,
- Ongoing chemotherapy and/or radiotherapy treatment,
- Active progression of breast cancer,
- History of neurological or psychiatric conditions,
- Major disturbances in comprehension that prevent them giving free, informed consent,
- Pregnant, parturient or breastfeeding women,
- Person under a legal protection measure such as guardianship or curatorship,
- People not affiliated to a social security scheme (French Social Security) or beneficiaries of a similar scheme.
Key Trial Info
Start Date :
December 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 17 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04808674
Start Date
December 17 2021
End Date
July 17 2025
Last Update
January 13 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon - Groupement hospitalier sud - Hôpital Henry Gabrielle - Service de médecine physique et de réadaptation
Lyon, France, 69230
2
Hôpital Pontchaillou - Service de Médecine Physique et de Réadaptation
Rennes, France, 35000